Hyperfine is collaborating with NVIDIA to advance the AI capabilities of the Swoop Portable magnetic resonance imaging (MRI) ...

On Tuesday, Citi analysts initiated a 90-day downside short-term view on Illumina stock (NASDAQ:ILMN), citing several significant challenges that the company is currently facing. The stock has already ...

Tuesday, Wolfe Research analysts maintained their Outperform rating on Illumina stock (NASDAQ:ILMN), keeping the price target at $150.00 despite recent developments. Currently trading at $88.74, the ...

SAN DIEGO - Illumina, Inc. (NASDAQ: NASDAQ:ILMN), a $4.37 billion revenue genomics leader with an impressive 68.37% gross margin, today announced a comprehensive suite of new omics technologies, ...

Trade war with China? Check. Cuts to scientific research? Check.

Illumina, Inc., a global leader in next-generation sequencing and array-based technologies, announced a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers explore cellular behavior mapped across complex tissues. The announcement ...

BEIJING’S surprise move to blacklist Illumina has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant. While Illumina is still assessing the ...

Enabled on Illumina sequencers and a new multimodal analysis platform, Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity.